The top 5 OncLive TV videos of the week cover insights in ovarian cancer, breast cancer, head and neck cancer, pancreatic cancer, and follicular lymphoma.
Related to this article
Patients who received MBTF prior to allo-HSCT achieved promising survival outcomes and manageable safety in relapsed/refractory acute myeloid leukemia.
Faculty convened for a virtual OncLive Scientific Interchange and Workshop to interpret emerging trial data and treatment strategies for systemic mastocytosis.
Advertisement
Advertisement
Trending on OncLive
1
Sevabertinib Approved in Japan for HER2-Mutant Non–Small Cell Lung Cancer
2
Dr Ayanambakkam on the FIT-001 Study in Renal Cell Carcinoma
3
Mayo Clinic Study Estimates Cancer Risk in Patients With Pancreatic Cysts, Advancing Early Detection
4
MBTF Before Allo-HSCT Produces Durable Efficacy and Manageable GVHD in R/R AML
5